Costs associated with community acquired pneumonia in France

Grèce Saba, Luiz Andrade (), Jacques Gaillat, Pierre Bonnin, Christian Chidiac, Hajnal-Gabriela Illes, Henri Laurichesse, Jonathan Messika, Jean-Damien Ricard, Bruno Detournay, Patrick Petitpretz and Gérard Pouvourville ()
Additional contact information
Grèce Saba: ESSEC Business School
Jacques Gaillat: CH d’Annecy Genevois
Pierre Bonnin: CH d’Annecy Genevois
Christian Chidiac: Hôpital de la Croix Rousse
Hajnal-Gabriela Illes: Hôpital Gabriel Montpied, CHU de Clermont-Ferrand
Henri Laurichesse: Hôpital Gabriel Montpied, CHU de Clermont-Ferrand
Jonathan Messika: AP-HP, Hôpital Louis Mourier, Service de Réanimation Médico-Chirurgicale
Jean-Damien Ricard: AP-HP, Hôpital Louis Mourier, Service de Réanimation Médico-Chirurgicale
Bruno Detournay: CEMKA-EVAL
Patrick Petitpretz: Hôpital André Mignot
Gérard Pouvourville: ESSEC Business School

The European Journal of Health Economics, 2018, vol. 19, issue 4, No 5, 533-544

Abstract: Abstract Objectives Pneumocost is a prospective study that aimed at documenting the costs of the management of patients hospitalized with a pneumococcal pneumonia and the post-discharge costs during a 6-month period in the French context. Methods Billing data were used to document hospital costs. Resource use during the follow-up period was collected through phone interviews at month 1, 3 and 6. Descriptive statistics and multivariate analyses were performed. We used generalized linear models with log-link functions to estimate parameters associated with hospital and follow-up costs of patients. Results Five hundred twenty-four patients were enrolled in 40 public centers from October 2011 to April 2014. Average age was 63 (SD 17); 55.0% of them were male. Average length of stay was 15 days (SD 23). Average cost of stay for the French Sickness Fund was €7293 (SD €7363). Average cost of follow-up was €1242 (SD €3000) and decreased steadily through time. When controlling for patient’s socioeconomic characteristics, severity of disease and hospital stay, results showed a concave relationship between hospital costs and age. Obesity, the severity of the disease and comorbidities were associated with constantly increasing inpatient costs. Concerning follow-up costs, we found the same concave relationship with age, while gender, a history of pneumonia and severity of the disease were the most important predictors of high costs after discharge. Conclusion Pneumocost is the first French study providing a robust estimation of the cost of managing invasive pneumococcal pneumonia in the French context.

Keywords: Cost study; Pneumococcal pneumonia; France (search for similar items in EconPapers)
JEL-codes: I10 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10198-017-0900-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:19:y:2018:i:4:d:10.1007_s10198-017-0900-z

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-017-0900-z

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().